These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 24571922)
21. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
23. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465 [TBL] [Abstract][Full Text] [Related]
24. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481 [TBL] [Abstract][Full Text] [Related]
25. Role of NADPH oxidase in retinal vascular inflammation. Al-Shabrawey M; Rojas M; Sanders T; Behzadian A; El-Remessy A; Bartoli M; Parpia AK; Liou G; Caldwell RB Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3239-44. PubMed ID: 18378574 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
28. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Behl Y; Krothapalli P; Desta T; DiPiazza A; Roy S; Graves DT Am J Pathol; 2008 May; 172(5):1411-8. PubMed ID: 18403591 [TBL] [Abstract][Full Text] [Related]
29. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Cui B; Sun JH; Xiang FF; Liu L; Li WJ Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442 [TBL] [Abstract][Full Text] [Related]
30. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381 [TBL] [Abstract][Full Text] [Related]
31. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613 [TBL] [Abstract][Full Text] [Related]
32. Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. Khalfaoui T; Lizard G; Ouertani-Meddeb A J Mol Histol; 2008 Apr; 39(2):243-9. PubMed ID: 18165914 [TBL] [Abstract][Full Text] [Related]
33. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo. Hattori T; Matsubara A; Taniguchi K; Ogura Y Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425 [TBL] [Abstract][Full Text] [Related]
34. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
35. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats. Zhu Y; Zhang XL; Zhu BF; Ding YN Mol Biol Rep; 2012 Apr; 39(4):3727-35. PubMed ID: 21952821 [TBL] [Abstract][Full Text] [Related]
36. VEGF164 is proinflammatory in the diabetic retina. Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656 [TBL] [Abstract][Full Text] [Related]
37. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats. Jian W; Yu S; Tang M; Duan H; Huang J J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279 [TBL] [Abstract][Full Text] [Related]
38. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. Miyahara S; Kiryu J; Yamashiro K; Miyamoto K; Hirose F; Tamura H; Katsuta H; Nishijima K; Tsujikawa A; Honda Y Am J Pathol; 2004 May; 164(5):1697-706. PubMed ID: 15111316 [TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory role of sesamin in STZ induced mice model of diabetic retinopathy. Ahmad S; ElSherbiny NM; Jamal MS; Alzahrani FA; Haque R; Khan R; Zaidi SK; AlQahtani MH; Liou GI; Bhatia K J Neuroimmunol; 2016 Jun; 295-296():47-53. PubMed ID: 27235348 [TBL] [Abstract][Full Text] [Related]
40. Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin-induced diabetic rats. Lei X; He J; Ren C; Zhou Y; Chen X; Dou J Biomed Pharmacother; 2018 Feb; 98():643-650. PubMed ID: 29289839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]